Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Instagram Outage Disrupts Thousands of U.S. Users 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
OneSource Regulatory™ introduces MyIndago™
|
||||||
The first FREE Search and Discussion Solution to Search FDA Warning and Enforcement Actions, and Office of Inspector General (OIG) Corporate Integrity Agreements and OIG Advisory Opinions
CHICAGO, IL, October 16, 2017 – OneSource Regulatory™ (OSR), the premier specialized technology-enabled professional services firm, today announced a free technology solution for individuals working in the life sciences industry, with the launch of MyIndago™.
MyIndago™ is the most effective solution for professionals working in the highly-regulated FDA environment, striving to help pharmaceutical companies maintain compliance. With MyIndago™, individuals can easily search and access FDA enforcement communications to gain transparency into what has been problematic according to the FDA. Typically, this information is posted by the FDA at the time of communication and can be accessed on their webpage, but it is not easily searchable or cataloged within a user-friendly environment. Instead of a high-priced subscription database, available only to employees in the largest organizations, MyIndago™ is a free solution available to everyone.
Co-founder and visionary of OSR, Tracy Rockney, speaks to the value of MyIndago™ as an innovative technology: “With MyIndago™, accurate information is readily available to empower decision-making to anyone, at all levels of the organization.”
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/47cf2750-9c2c-41c9-b97e-826e97ccee57
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/dcf3fa31-838e-4766-8f6c-bfb4c8f7ad38
Tracy D. Rockney-Ward OneSource Regulatory +1 (833) OSR-TEAM [email protected]
